Position in AMRN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$25,121
+$17,458 QoQ
Shares Held
1,576
+197.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 80 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $102,948,956 across 18 Drug Manufacturers - General names. AMRN ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,845 | $30,999,270 | |
| 2 | JNJ |
Johnson & Johnson
|
78,530 | $19,944,264 | |
| 3 | ABBV |
AbbVie Inc.
|
68,002 | $17,112,023 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,992 | $12,206,472 | |
| 5 | AMGN |
Amgen Inc
|
18,395 | $6,661,197 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
34,746 | $4,389,809 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
52,327 | $3,015,081 | |
| 8 | NVS |
Novartis AG
|
14,066 | $2,204,423 |
All Filings in AMRN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,121 | 1,576 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $7,663 | 530 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $3,713 | 266 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $3,865 | 236 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $1,313 | 81 | Shares | Defined | 2025-07-14 | |
| 2024-06-30 | $418 | 607 | Shares | Defined | 2024-07-02 | |
| 2024-03-31 | $648 | 729 | Shares | Defined | 2024-04-05 | |
| 2023-12-31 | $475 | 546 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||